Clostridium Chauvoei, F, Kb; Clostridium Novyi, 8296, Kb; Clostridium Perfringen

36 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

7780.0%

Death Rate

Active Ingredients

Clostridium Chauvoei, F, Kb; Clostridium Novyi, 8296, Kb; Clostridium Perfringen

Administration Routes

SubcutaneousUnknownIntramuscular

Species Affected

Cattle 35

Unknown 1

Most Affected Breeds

Cattle (other) 27

Crossbred Bovine/Cattle 5

Aberdeen Angus 1

Cattle (unspecified) 1

Cattle (unknown) 1

Unknown 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 30

Death 20

Lack of efficacy - NOS 8

CULTURE/TITER DATA ABNORMAL 7

DEATH-TREATMENT FAILURE 6

PR-LUNG(S), LESION(S) 5

Death by euthanasia 2

Injection site lump 2

Copper deficiency signs 1

Illness NOS 1

Temporary blindness 1

Aggression 1

Outcome Breakdown

Died

28 (43.1%)

Outcome Unknown

22 (33.8%)

Ongoing

7 (10.8%)

Recovered/Normal

5 (7.7%)

Recovered with Sequela

2 (3.1%)

Euthanized

1 (1.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.